Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2

被引:0
|
作者
Koshelskaya, Olga A. [1 ]
Kharitonova, Olga A. [1 ]
Kologrivova, Irina, V [1 ]
Suslova, Tatiana E. [1 ]
Margolis, Natalia Yu [1 ]
Tereshenkova, Ekaterina K. [1 ]
Rybina, Anastasiia N. [1 ]
Karpov, Rostislav S. [1 ]
机构
[1] Tomsk Natl Res Ctr Med, Tomsk, Russia
关键词
coronary atherosclerosis; diabetes mellitus; epicardial adipose tissue thickness; EPICARDIAL ADIPOSE-TISSUE; FAT THICKNESS; INSULIN-RESISTANCE; HEART; ASSOCIATION; THERAPY; GLUCOSE; VOLUME;
D O I
10.26442/00403660.2021.09.201032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study interconnections between epicardial adipose tissue thickness (EATt), parameters of glucose metabolism/insulin, C-reactive protein (hsCRP), serum adipokines and severity of coronary artery disease (CAD) depending on the presence of diabetes mellitus type 2 (DM 2); to determine significant markers of CAD severity in patients with DM 2. Materials and methods. The study involved 106 patients with CAD (m/f - 64/42, 60.9 +/- 6.8 years), including patients with DM 2 (group 1, n=35) and non-diabetic patients (group 2, n=71). Severity of CAD was evaluated according to angiography data with calculation of Gensini Score (GS). EATt was assessed via echocardiography. Serum levels of glucose/insulin metabolism parameters, lipid fractions, hsCRP and adipokines were evaluated. Clinical parameters, including GS, did not differ between groups. Results. EAT thickness median was elevated in gr.1 (5.1 mm vs. 4.4 mm in group 2), while adiponectin levels were decreased (6.55 mu g/ml vs. 7.71 mu g/ml). Linear regression of body mass index and resistin levels on EATt was revealed in gr.1; in gr.2 EATt linearly increased with waist circumference increment when EATt<6 mm. Linear regression of EATt on GS was revealed in gr.1 when EATt<8 mm, while linear regression in the whole GS range was obtained for HDL-C and hsCRP levels. Conclusion. Study results demonstrate differences in mechanisms of deposition and functioning of epicardial and abdominal adipose tissue depending on the presence or absence of diabetic status. Patients with DM2 are characterized by the excessive EAT deposition and decrease of serum adiponectin levels compared to non-diabetic patients in the equal conditions. Independent markers of CAD severity in DM 2 are decreased HDL-C and increased hsCRP levels, but not EATt.
引用
收藏
页码:1030 / 1036
页数:7
相关论文
共 50 条
  • [1] Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
    Ikmal, Sharifah Intan Qhadijah Syed
    Huri, Hasniza Zaman
    Vethakkan, Shireene Ratna
    Ahmad, Wan Azman Wan
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013
  • [2] Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
    Gerstein, Hertzel C.
    Ratner, Robert E.
    Cannon, Christopher P.
    Serruys, Patrick W.
    Garcia-Garcia, Hector M.
    van Es, Gerrit-Anne
    Kolatkar, Nikheel S.
    Kravitz, Barbara G.
    Miller, Diane M.
    Huang, Chun
    Fitzgerald, Peter J.
    Nesto, Richard W.
    CIRCULATION, 2010, 121 (10) : 1176 - 1187
  • [3] Diffuse atherosclerosis in type 2 diabetes mellitus with coronary artery disease
    Watanabe, Y
    Nakagawa, S
    Hirotani, T
    Atsumi, Y
    Kameda, T
    Matsuoka, K
    DIABETES, 2000, 49 : A151 - A151
  • [4] Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus
    Genkel, V. V.
    Salashenko, A. O.
    Shamaeva, T. N.
    Sumerkina, V. A.
    Nikushkina, K., V
    Shaposhnik, I. I.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (10) : 54 - 62
  • [5] Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease
    Koshelskaya, Olga A.
    Suslova, Tatiana E.
    Kologrivova, Irina, V
    Margolis, Natalia Y.
    Zhuravleva, Olga A.
    Kharitonova, Olga A.
    Vinnitskaya, Irina V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2020, 16 (01) : 4 - 9
  • [6] Intermediate Monocytes and Circulating Endothelial Cells: Interplay with Severity of Atherosclerosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus
    Kologrivova, Irina V.
    Suslova, Tatiana E.
    Koshelskaya, Olga A.
    Kravchenko, Elena S.
    Kharitonova, Olga A.
    Romanova, Ekaterina A.
    Vyrostkova, Alexandra I.
    Boshchenko, Alla A.
    BIOMEDICINES, 2023, 11 (11)
  • [7] BIOMARKERS OF CORONARY ATHEROSCLEROSIS VERSUS PERIPHERAL ARTERIAL DISEASE IN TYPE 2 DIABETES MELLITUS
    Eraso, Luis H.
    Ginwala, Naeema
    Qasim, Atif N.
    Mehta, Nehal N.
    Reilly, Muredach P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [8] Metabolic therapy for patients with diabetes mellitus and coronary artery disease
    Rosano, Giuseppe M. C.
    Vitale, Cristiana
    Fragasso, Gabriele
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (5A): : 14J - 18J
  • [9] Silent coronary artery disease in patients with type 2 diabetes mellitus
    Gokcel, A
    Aydin, M
    Yalcin, F
    Yapar, AF
    Ertorer, ME
    Ozsahin, AK
    Muderrisoglu, H
    Aktas, A
    Guvener, N
    Akbaba, M
    ACTA DIABETOLOGICA, 2003, 40 (04) : 176 - 180
  • [10] Silent coronary artery disease in patients with type 2 diabetes mellitus
    A. Gokcel
    M. Aydin
    F. Yalcin
    A. F. Yapar
    M. E. Ertorer
    A. K. Ozsahin
    H. Muderrisoglu
    A. Aktas
    N. Guvener
    M. Akbaba
    Acta Diabetologica, 2003, 40 : 176 - 180